Evidence map›Paper›PMID 40313553›Full record

ArticleFrontiers in medicine2025

Chest radiographs in acute respiratory distress syndrome: an Achilles' heel of the Berlin criteria?

Miguel Bardají-Carrillo, Marta Martín-Fernández, Rocío López-Herrero, Juan M Priede-Vimbela, Irene Arroyo-Hernantes, Rosa Cobo-Zubia, Rosa Prieto-Utrera, Esther Gómez-Sánchez, Jesús Villar, Eduardo Tamayo

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miguel Bardají-CarrilloBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Marta Martín-FernándezBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Rocío López-HerreroBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Juan M Priede-VimbelaBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Irene Arroyo-HernantesBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Rosa Cobo-ZubiaBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Rosa Prieto-UtreraBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Esther Gómez-SánchezBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.
Jesús VillarCIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Eduardo TamayoBioCritic, Group for Biomedical Research in Critical Care Medicine, Valladolid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the high mortality and economic burden associated with the acute respiratory distress syndrome (ARDS), the role of chest radiograph (CXR) in ARDS diagnosis and prognosis remains uncertain. The purpose of this study is to elucidate clinical characteristics that distinguish ARDS patients from those without ARDS, especially in patients where CXRs are indicative of ARDS. Methods: Secondary analysis of a prospective observational study with 454 postoperative septic patients under mechanical ventilation (MV). Patients were stratified in two groups depending on whether they met the Berlin criteria for ARDS. Primary outcome was identification of clinical characteristics differentiating patients with ARDS confirmed by CXR from non-ARDS patients. Secondary outcome was 60-day in-hospital mortality of postoperative sepsis-induced ARDS. Results: One hundred thirty-nine patients (30.6%) had CXRs compatible with ARDS, although ARDS was confirmed in only 45 patients (9.9%). Emergency surgery (OR 6.6), abdominal source of infection (OR 6.0), pneumonia (OR 8.2), and higher lactate (OR 3.9) were clinical features associated with ARDS development confirmed by CXR. ARDS was an independent risk factor for 60-day mortality (OR 1.8). Conclusion: Although CXR criteria for ARDS diagnosis could be replaced in future definitions, its importance for ARDS diagnosis should not be underestimated.

Indexed as

60-day mortalityacute respiratory distress syndromechest radiographsemergency surgerypostoperative sepsis

Identifiers

PMID40313553
PMCPMC12043692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.